[1]
Ibrahim MS, Samuel B, Mohamed W, Suchdev K. Cardiac Dysfunction in Neurocritical Care: An Autonomic Perspective. Neurocritical care. 2019 Jun:30(3):508-521. doi: 10.1007/s12028-018-0636-3. Epub
[PubMed PMID: 30484009]
Level 3 (low-level) evidence
[2]
La Rovere MT, Christensen JH. The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs. Vascular pharmacology. 2015 Aug:71():1-10. doi: 10.1016/j.vph.2015.02.005. Epub 2015 Apr 11
[PubMed PMID: 25869497]
[3]
Wehrwein EA, Orer HS, Barman SM. Overview of the Anatomy, Physiology, and Pharmacology of the Autonomic Nervous System. Comprehensive Physiology. 2016 Jun 13:6(3):1239-78. doi: 10.1002/cphy.c150037. Epub 2016 Jun 13
[PubMed PMID: 27347892]
Level 3 (low-level) evidence
[4]
Patel HC, Rosen SD, Lindsay A, Hayward C, Lyon AR, di Mario C. Targeting the autonomic nervous system: measuring autonomic function and novel devices for heart failure management. International journal of cardiology. 2013 Dec 10:170(2):107-17. doi: 10.1016/j.ijcard.2013.10.058. Epub 2013 Oct 25
[PubMed PMID: 24200312]
[5]
Gaitonde S, Malik RD, Christie AL, Zimmern PE. Bethanechol: Is it still being prescribed for bladder dysfunction in women? International journal of clinical practice. 2019 Aug:73(8):e13248. doi: 10.1111/ijcp.13248. Epub 2018 Aug 15
[PubMed PMID: 30112787]
[6]
Mogil RS, Khezri N, Ren R, Adleyba O, Abumasmah R, Ghassibi MP, Chien JL, Pearlstein A, Patthanathamrongkasem T, Liebmann JM, Ritch R, Park SC. Changes in Iridocorneal Angle and Anterior Chamber Structure in Eyes With Anatomically Narrow Angles: Laser Iridotomy Versus Pilocarpine. Journal of glaucoma. 2018 Dec:27(12):1073-1078. doi: 10.1097/IJG.0000000000001097. Epub
[PubMed PMID: 30256278]
[7]
Watkins SL, Thrul J, Max W, Ling PM. Cold Turkey and Hot Vapes? A National Study of Young Adult Cigarette Cessation Strategies. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2020 Apr 21:22(5):638-646. doi: 10.1093/ntr/nty270. Epub
[PubMed PMID: 30590749]
[8]
Kumar A, Mehta V, Raj U, Varadwaj PK, Udayabanu M, Yennamalli RM, Singh TR. Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents. Current Alzheimer research. 2019:16(2):116-127. doi: 10.2174/1567205016666181212155147. Epub
[PubMed PMID: 30543170]
Level 1 (high-level) evidence
[9]
Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease. British journal of pharmacology. 2017 Dec:174(23):4224-4232. doi: 10.1111/bph.14030. Epub 2017 Oct 29
[PubMed PMID: 28901528]
[10]
Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, McLeod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 20:140(8):e382-e482. doi: 10.1161/CIR.0000000000000628. Epub 2018 Nov 6
[PubMed PMID: 30586772]
Level 1 (high-level) evidence
[11]
Aziz MIA, Tan LE, Wu DB, Pearce F, Chua GSW, Lin L, Tan PT, Ng K. Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International journal of chronic obstructive pulmonary disease. 2018:13():3203-3231. doi: 10.2147/COPD.S173472. Epub 2018 Oct 9
[PubMed PMID: 30349228]
Level 2 (mid-level) evidence
[12]
Dohar JE. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis. International journal of pediatric otorhinolaryngology. 2019 Jan:116():97-101. doi: 10.1016/j.ijporl.2018.10.035. Epub 2018 Oct 24
[PubMed PMID: 30554718]
[13]
Herbison P, McKenzie JE. Which anticholinergic is best for people with overactive bladders? A network meta-analysis. Neurourology and urodynamics. 2019 Feb:38(2):525-534. doi: 10.1002/nau.23893. Epub 2018 Dec 21
[PubMed PMID: 30575999]
Level 1 (high-level) evidence
[14]
Alammar N, Stein E. Irritable Bowel Syndrome: What Treatments Really Work. The Medical clinics of North America. 2019 Jan:103(1):137-152. doi: 10.1016/j.mcna.2018.08.006. Epub
[PubMed PMID: 30466670]
[15]
Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Anesthesiology. 2016 Oct:125(4):647-55. doi: 10.1097/ALN.0000000000001279. Epub
[PubMed PMID: 27496656]
[16]
Ohar J, Tosiello R, Goodin T, Sanjar S. Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. International journal of chronic obstructive pulmonary disease. 2019:14():27-37. doi: 10.2147/COPD.S184808. Epub 2018 Dec 18
[PubMed PMID: 30587959]
[17]
Schuster Bruce C, Rull G, Sotiris A, Lobo MD. Novel stratified medicines approach to manage uncontrolled hypertension due to multiple drug intolerances. BMJ case reports. 2018 Dec 13:11(1):. doi: 10.1136/bcr-2018-226045. Epub 2018 Dec 13
[PubMed PMID: 30567232]
Level 3 (low-level) evidence
[18]
Kislitsina ON, Rich JD, Wilcox JE, Pham DT, Churyla A, Vorovich EB, Ghafourian K, Yancy CW. Shock - Classification and Pathophysiological Principles of Therapeutics. Current cardiology reviews. 2019:15(2):102-113. doi: 10.2174/1573403X15666181212125024. Epub
[PubMed PMID: 30543176]
[19]
Beavers CJ, Pandya KA. Pharmacotherapy Considerations for the Management of Advanced Cardiac Life Support. The Nursing clinics of North America. 2016 Mar:51(1):69-82. doi: 10.1016/j.cnur.2015.10.003. Epub 2016 Jan 13
[PubMed PMID: 26897425]
[20]
Gardiner MA, Wilkinson MH. Randomized Clinical Trial Comparing Breath-Enhanced to Conventional Nebulizers in the Treatment of Children with Acute Asthma. The Journal of pediatrics. 2019 Jan:204():245-249.e2. doi: 10.1016/j.jpeds.2018.08.083. Epub 2018 Nov 2
[PubMed PMID: 30392872]
Level 1 (high-level) evidence
[22]
Sahney A, Sharma BC, Jindal A, Anand L, Arora V, Vijayaraghavan R, Dhamija RM, Kumar G, Bhardwaj A, Sarin SK. A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism. Liver international : official journal of the International Association for the Study of the Liver. 2019 Apr:39(4):684-693. doi: 10.1111/liv.14024. Epub 2019 Feb 4
[PubMed PMID: 30554466]
Level 1 (high-level) evidence
[23]
Wu YP, Wang YB, Wu ZB. Bromocriptine-responsive supersellar germinoma with the expression of dopamine receptors: A case report. Clinical neurology and neurosurgery. 2019 Jan:176():15-18. doi: 10.1016/j.clineuro.2018.11.006. Epub 2018 Nov 10
[PubMed PMID: 30476699]
Level 3 (low-level) evidence
[24]
Falhammar H, Kjellman M, Calissendorff J. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center. Endocrine. 2018 Dec:62(3):566-575. doi: 10.1007/s12020-018-1734-x. Epub 2018 Sep 15
[PubMed PMID: 30220006]
Level 3 (low-level) evidence
[25]
Zabkowski T, Saracyn M. Drug adherence and drug-related problems in pharmacotherapy for lower urinary tract symptoms related to benign prostatic hyperplasia. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2018 Aug:69(4):. doi: 10.26402/jpp.2018.4.14. Epub 2018 Dec 9
[PubMed PMID: 30552307]
[26]
Parch J, Powell C. No longer failing to treat heart failure: A guideline update review. JAAPA : official journal of the American Academy of Physician Assistants. 2019 Jan:32(1):11-15. doi: 10.1097/01.JAA.0000550282.19722.93. Epub
[PubMed PMID: 30589728]
[27]
Philipp M, Brede M, Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. American journal of physiology. Regulatory, integrative and comparative physiology. 2002 Aug:283(2):R287-95
[PubMed PMID: 12121839]
Level 2 (mid-level) evidence
[28]
do Vale GT, Ceron CS, Gonzaga NA, Simplicio JA, Padovan JC. Three Generations of β-blockers: History, Class Differences and Clinical Applicability. Current hypertension reviews. 2019:15(1):22-31. doi: 10.2174/1573402114666180918102735. Epub
[PubMed PMID: 30227820]
[29]
Bradley SJ, Tobin AB, Prihandoko R. The use of chemogenetic approaches to study the physiological roles of muscarinic acetylcholine receptors in the central nervous system. Neuropharmacology. 2018 Jul 1:136(Pt C):421-426. doi: 10.1016/j.neuropharm.2017.11.043. Epub 2017 Nov 27
[PubMed PMID: 29191752]
[30]
Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. British journal of pharmacology. 2015 Jan:172(1):1-23
[PubMed PMID: 25671228]
[34]
Moustafa GA, Borkar DS, McKay KM, Eton EA, Koulisis N, Lorch AC, Kloek CE, PCIOL Study Group. Outcomes in resident-performed cataract surgeries with iris challenges: Results from the Perioperative Care for Intraocular Lens study. Journal of cataract and refractive surgery. 2018 Dec:44(12):1469-1477. doi: 10.1016/j.jcrs.2018.08.019. Epub 2018 Nov 1
[PubMed PMID: 30391157]
[35]
Adams CM, Stacy R, Rangaswamy N, Bigelow C, Grosskreutz CL, Prasanna G. Glaucoma - Next Generation Therapeutics: Impossible to Possible. Pharmaceutical research. 2018 Dec 13:36(2):25. doi: 10.1007/s11095-018-2557-4. Epub 2018 Dec 13
[PubMed PMID: 30547244]
[36]
Pecikoza U, Micov A, Tomić M, Stepanović-Petrović R. Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors. Life sciences. 2018 Dec 1:214():167-175. doi: 10.1016/j.lfs.2018.10.059. Epub 2018 Oct 27
[PubMed PMID: 30393024]
[37]
Araklitis G, Thiagamoorthy G, Hunter J, Rantell A, Robinson D, Cardozo L. Anticholinergic prescription: are healthcare professionals the real burden? International urogynecology journal. 2017 Aug:28(8):1249-1256. doi: 10.1007/s00192-016-3258-3. Epub 2017 Jan 13
[PubMed PMID: 28091711]
[38]
Bozkurt B, Okudan N, Belviranli M, Oflaz AB. The evaluation of intraocular pressure fluctuation in glaucoma subjects during submaximal exercise using an ocular telemetry sensor. Indian journal of ophthalmology. 2019 Jan:67(1):89-94. doi: 10.4103/ijo.IJO_585_18. Epub
[PubMed PMID: 30574900]
[39]
Simmons J, Ventetuolo CE. Cardiopulmonary monitoring of shock. Current opinion in critical care. 2017 Jun:23(3):223-231. doi: 10.1097/MCC.0000000000000407. Epub
[PubMed PMID: 28398907]
Level 3 (low-level) evidence
[40]
Bokov P, Delclaux C. [Interpretation and use of routine pulmonary function tests: Spirometry, static lung volumes, lung diffusion, arterial blood gas, methacholine challenge test and 6-minute walk test]. La Revue de medecine interne. 2016 Feb:37(2):100-10. doi: 10.1016/j.revmed.2015.10.356. Epub 2015 Dec 3
[PubMed PMID: 26657268]
[41]
Schultz KE, Lui GK, McElhinney DB, Long J, Balasubramanian V, Sakarovitch C, Fernandes SM, Dubin AM, Rogers IS, Romfh AW, Motonaga KS, Viswanathan MN, Ceresnak SR. Extended cardiac ambulatory rhythm monitoring in adults with congenital heart disease: Arrhythmia detection and impact of extended monitoring. Congenital heart disease. 2019 May:14(3):410-418. doi: 10.1111/chd.12736. Epub 2019 Jan 3
[PubMed PMID: 30604934]
[42]
Cole JB, Orozco BS, Arens AM. Physostigmine Reversal of Dysarthria and Delirium After Iatrogenic Atropine Overdose From a Dental Procedure. The Journal of emergency medicine. 2018 Jun:54(6):e113-e115. doi: 10.1016/j.jemermed.2018.02.046. Epub 2018 Apr 19
[PubMed PMID: 29681419]
[43]
Seger DL, Loden JK. Naloxone reversal of clonidine toxicity: dose, dose, dose. Clinical toxicology (Philadelphia, Pa.). 2018 Oct:56(10):873-879. doi: 10.1080/15563650.2018.1450986. Epub 2018 Mar 16
[PubMed PMID: 29544366]
[44]
Lafarge L, Bourguignon L, Bernard N, Vial T, Dehan-Moya MJ, De La Gastine B, Goutelle S. [Pharmacokinetic risk factors of beta-blockers overdose in the elderly: Case report and pharmacology approach]. Annales de cardiologie et d'angeiologie. 2018 Apr:67(2):91-97. doi: 10.1016/j.ancard.2018.02.001. Epub 2018 Mar 12
[PubMed PMID: 29544975]
Level 3 (low-level) evidence